Full-Time

Research Associate

Immunopeptidomics & Mass Spectometry

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Junior, Mid, Senior

Cambridge, MA, USA

Expected to be in office 70% of the time with flexibility to work from home up to 30%.

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
Python
R
Requirements
  • Bachelor’s degree in Immunology, Biochemistry, Molecular Biology, or a related field plus 2 years experience
  • Experience with proteomic sample processing workflows including protein digestion, pull-down assays (affinity-tag or immunoprecipitation), and peptide desalting and fractionation
  • Experience operating nano-liquid chromatography-mass spectrometry (nLC-MS) systems
  • Familiarity with bioinformatics tools and software used for mass spectrometry data analysis
  • Ability to manage multiple projects in a fast-paced environment with aggressive timelines
  • Excellent interpersonal and communication skills, with a collaborative mindset and the ability to build strong relationships with internal and external stakeholders
  • A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative
  • A passion for innovation and the mission of developing transformative medicines in the fight against cancer
  • Experience with immunopeptidomics workflows
  • Hands-on experience with quantitative mass spectrometry assays
  • Familiarity with Bruker timsTOF instruments and PASEF® data acquisition methods
  • Proficiency with the following software programs: R, Python™, FragPipe, Spectronaut®, and Skyline
Responsibilities
  • Perform sample preparation, nano-liquid chromatography-mass spectrometry (nLC-MS) data acquisition, as well as data analysis and data interpretation to aid in the discovery and validation of tumor-associated antigens and neoantigens
  • Take part in regular upkeep of instruments and perform system suitability evaluations
  • Maintain detailed, timely, organized records, including lab notebook entries to ensure accurate documentation of experiments, observations, and results
  • Maintain up-to-date knowledge of literature in the field proteomics, immunopeptidomics, and cancer vaccines
  • Contribute to the writing of IND reports
  • Present findings at internal meetings

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?